0001735726-18-000001.txt : 20180328 0001735726-18-000001.hdr.sgml : 20180328 20180328152938 ACCESSION NUMBER: 0001735726-18-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20180328 DATE AS OF CHANGE: 20180328 EFFECTIVENESS DATE: 20180328 FILER: COMPANY DATA: COMPANY CONFORMED NAME: OncoNano Medicine, Inc. CENTRAL INDEX KEY: 0001735726 IRS NUMBER: 811713330 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-308806 FILM NUMBER: 18718386 BUSINESS ADDRESS: STREET 1: 5323 HARRY HINES BLVD. CITY: DALLAS STATE: TX ZIP: 75390 BUSINESS PHONE: (408) 476-1904 MAIL ADDRESS: STREET 1: 5323 HARRY HINES BLVD. CITY: DALLAS STATE: TX ZIP: 75390 D 1 primary_doc.xml X0708 D LIVE 0001735726 OncoNano Medicine, Inc. 5323 HARRY HINES BLVD. DALLAS TX TEXAS 75390 (408) 476-1904 DELAWARE None None Corporation true 2014 Ravi Srinivasan 5323 Harry Hines Blvd. Dallas TX TEXAS 75093 Executive Officer Director John Dyett c/o OncoNano Medicine, Inc. 5323 Harry Hines Blvd. Dallas TX TEXAS 75093 Director Alvaro Guillem c/o OncoNano Medicine, Inc. 5323 Harry Hines Blvd. Dallas TX TEXAS 75093 Director Paritosh Dhawale c/o OncoNano Medicine, Inc. 5323 Harry Hines Blvd. Dallas TX TEXAS 75093 Director Joydeep Goswami c/o OncoNano Medicine, Inc. 5323 Harry Hines Blvd. Dallas TX TEXAS 75093 Director Biotechnology Decline to Disclose 06b false 2018-03-13 false true true false 0 Salem Partners LLC 43363 None None 11111 Santa Monica Blvd., Suite 2250 Los Angeles CA CALIFORNIA 90025 AL ALABAMA AZ ARIZONA CA CALIFORNIA CO COLORADO CT CONNECTICUT DE DELAWARE DC DISTRICT OF COLUMBIA FL FLORIDA GA GEORGIA HI HAWAII IL ILLINOIS MD MARYLAND MA MASSACHUSETTS MI MICHIGAN MN MINNESOTA MS MISSISSIPPI MO MISSOURI NV NEVADA NJ NEW JERSEY NY NEW YORK NC NORTH CAROLINA OR OREGON PA PENNSYLVANIA TN TENNESSEE TX TEXAS UT UTAH VA VIRGINIA WA WASHINGTON WI WISCONSIN WY WYOMING false 11658526 11658526 0 The total offering amount includes conversion of principal and interest under outstanding promissory notes. false 27 0 600000 The amount does not include a non-refundable retainer of $25,000 paid to the broker and a warrant to purchase 600,096 shares of common stock of the Issuer issued to the broker. 0 false OncoNano Medicine, Inc. /s/ Ravi Srinivasan Ravi Srinivasan President and CEO 2018-03-28